Malignant Brain Neoplasm — Trials

Malignant Brain Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

636 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 193
Recruiting: 112
Ph III recruiting: 4
Growth YoY: +9.4%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (99)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06388733	A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma	active not recruiting	Phase 3	450	Ivy Brain Tumor CenterOTHER	11	Jul 1, 2026	clinicaltrials
NCT05685004	Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)	active not recruiting	Phase 2 / Phase 3	120	TVAX BiomedicalINDUSTRY	1	Jul 1, 2025	clinicaltrials